Green Cross LabCell Obtains Patent for Natural Killer Cell Manufacturing Method
[Asia Economy Reporter Ji Yeon-jin] Green Cross LabCell announced on the 22nd that it has obtained a patent related to the manufacturing method of natural killer cells.
The patent pertains to the manufacturing method of natural killer (NK) cells, characterized by co-proliferating CD3-positive cell-depleted peripheral blood mononuclear cells and feeder cells, and re-stimulating the feeder cells when the peripheral blood mononuclear cells reach a specific cumulative number of divisions.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- CJ Group, Personal Information and Photos of Female Employees Leaked via Telegram
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
It also includes a method of manufacturing NK cells characterized by culturing NK cells under appropriate culture conditions using a bio-reactor.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
